JPMorgan raises McDonald’s stock price target to $270 on modernization

JPMorgan raised its McDonald’s price target to $270 from $250 and maintained an Overweight rating, but noted shares at $280 were above the new December 2027 target and preferred lower entry points. McDonald’s Q3 2026 adjusted EPS of $3.57 beat the $3.38 forecast, while revenue of $7.16 billion missed the $7.29 billion estimate; U.S. traffic improved toward quarter-end and international markets continued to gain. The company has a 2.75% dividend yield and has increased its dividend for 51 consecutive years.

Analysis

The signal is less “earnings beat” than a gap between profit delivery and top-line demand: the EPS upside alongside a revenue miss does not establish that traffic or sales momentum is broad-based. Late-quarter U.S. traffic improvement is a near-term catalyst to test in the next update, not yet evidence of a durable recovery. The key operating question is whether modernization and customer-facing investment can lift comparable sales and unit economics enough to justify its execution costs; strong system cash generation is an advantage, but not proof of attractive incremental returns.

Growth concentration is a two-sided exposure: China’s large share of expected unit additions raises the payoff if openings ramp, but makes the growth narrative more vulnerable to local demand, regulatory or geopolitical disruption. The lower China shares cited for YUM and QSR may mean less exposure to that upside and less concentration risk; they are not, by themselves, evidence of superior growth or a clean pair trade.

Near term, the target increase is not a fresh upside catalyst with MCD already above the stated December 2027 target. Over 1–3 months, watch U.S. traffic, comparable sales and revenue conversion; over 6–18 months, track new-unit productivity and returns on modernization. Contrarian risk: investors may over-credit a late-quarter traffic improvement while underweighting the revenue shortfall and China execution concentration. Conversely, a target below spot may be too cautious if traffic and investment returns improve; the supplied data do not establish valuation or consensus expectations well enough to call that mispricing.

Key Decisions for Investors

• Do not chase MCD on the EPS beat alone; the revenue miss and spot price above JPMorgan’s stated target leave an unfavorable entry setup on this information. Reassess after the next comparable-sales and traffic update.
• For existing MCD exposure, keep the position sized to tolerate China execution risk. Treat sustained U.S. traffic and comparable-sales improvement, alongside evidence of productive new openings, as confirmation; renewed traffic weakness or disappointing unit productivity would falsify the recovery thesis.
• Avoid a mechanical MCD-versus-YUM or MCD-versus-QSR pair based only on the cited China growth shares. Compare valuation, regional sales, unit returns and capital requirements first; those data are missing here.
• Watch for the next quarter’s revenue trend and management commentary on modernization investment returns. A continued profit beat without sales conversion would weaken the case for multiple expansion; improving sales with demonstrable unit-level returns would support revisiting the cautious stance.